Amoéba S.A.

ALMIB.PA

Agricultural Inputs · Basic Materials

Price

€0.69

-0.00 (-0.43%)

Market Cap

€53.5M

Exchange

Euronext Paris

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Share count rising — dilution

+287.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 17.8M (2021) → 68.9M (2025)

Winston Score History

The full picture

Amoéba S.A. is a small French biotech company that develops natural alternatives to chemical pesticides and disinfectants. Its core product is based on a living microorganism called Willaertia magna C2c Maky, a type of amoeba that can kill harmful bacteria and fungi. The company targets agricultural customers who want to reduce chemical use, as well as industrial water treatment markets.

Amoéba earns revenue by selling its biological crop protection products, though it is still in an early commercial stage and has not yet reached meaningful sales. The company operates primarily in Europe and is listed on the Euronext Growth Paris exchange. With a deeply negative return on capital and zero gross margin, Amoéba is essentially a pre-profit company that relies on fundraising to survive. The key risk is whether it can scale production, win regulatory approvals in new markets, and reach commercial viability before exhausting its cash resources.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+35.6% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€2M/ year

↓ Declining (-22% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

11.4%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 months

€5M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Amoéba S.A. has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

Data not available

Profit after running costs

Operating Margin

N/A

Data not available

Return on the money invested

ROCE

-76.4%

Weak — -76.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-100.0%

Shrinking sales (-100.0% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial